Mc Clanahan Mark A MD Fredericksburg, VA - 22408

Mc Clanahan Mark A MD is categorized under Health Practitioners in Fredericksburg, VA and active since 2001.

Mc Clanahan Mark A MD was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Health Practitioners business, which does work in the B2B market, and is classified as a Health Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Mark Mc Clanahan at the company’s single location by writing to 10711 Spotsylvania Avenue, Fredericksburg, Virginia VA 22408 or by phoning (540) 891-8499. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Mc Clanahan Mark A MD
Contact Person: Mark Mc Clanahan
Address: 10711 Spotsylvania Avenue, Fredericksburg, Virginia 22408
Phone Number: (540) 891-8499
Website Address: diabetesandthyroid.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Health Practitioners
SIC Code: 8049
NAICS Code: 6211110
Share This Business:

Mc Clanahan Mark A MD was started in 2001 to provide professional Health Practitioners under the SIC code 8049 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Mark Mc Clanahan for inquiries that concern Mc Clanahan Mark A MD by calling the company number (540) 891-8499, as your correspondence is most welcome. Additionally, the physical location of the single location of Mc Clanahan Mark A MD can be found at the coordinates 38.24878,-77.4943 as well as the street address 10711 Spotsylvania Avenue in Fredericksburg, Virginia 22408.

For its online presence, you may visit Mc Clanahan Mark A MD’s website at diabetesandthyroid.com and engage with its social media outlets through on Twitter and on Facebook.